Emisphere Technologies, Inc.
Edit Page
Report
Scan day: 05 February 2014 UTC
15
Virus safety - good
Description: Researches and develops proprietary technology for oral administration of proteins. Contains compant, technology, investor, career and contact information. Based in Tarrytown, New York. (Nasdaq: EMIS).
Emisphere is charting new frontiers in drug delivery. The Company's core business strategy is to use its proprietary Eligen Technology to develop novel oral forms of injectable drugs or poorly absorbed compounds.
Size: 217 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Emisphere - Eligen® Technology |
| Keywords: | emisphere, biosciences, eligen technology, oral drug delivery, oral insulin, oral heparin, oral acyclovir, oral pyy, oral gallium, human growth hormone, oral vitamin b12, oral glp-1, glp-1, type 2 diabetes |
| Description: | Emisphere is charting new frontiers in drug delivery. The Company's core business strategy is to use its proprietary Eligen® Technology to develop novel oral forms of injectable drugs or poorly absorbed compounds. |
| IP-address: | 207.56.175.75 |
WHOIS Info
| NS | Name Server: NS29.WORLDNIC.COM Name Server: NS30.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 05-dec-1995 Expiration Date: 04-dec-2015 |